Metabolic conjugation reduces in vitro toxicity of the flavonoid nevadensin

Area of Science:

• Pharmacology
• Toxicology
• Biochemistry

Background:

• Flavonoids, like nevadensin, are natural compounds with potential biological activities.
• Understanding the relationship between a compound's metabolism and its toxicity is crucial for drug development and risk assessment.
• Cell line-specific metabolic differences can significantly alter a compound's toxicological profile.

Purpose of the Study:

• To investigate the association between the metabolic capacity of different human carcinoma cell lines and the in vitro toxicity of the flavonoid nevadensin.
• To identify the metabolic pathways involved in nevadensin biotransformation and their role in its observed toxicity.
• To explore the potential involvement of specific enzymes, such as uridine 5'-diphospho (UDP)-glucuronosyltransferases (UGTs), in nevadensin metabolism.

Main Methods:

• Exposure of human colon (HT29), liver (HepG2), and bone marrow (KG1) carcinoma cells to nevadensin.
• High-resolution mass spectrometry and tandem mass spectrometry for analyzing nevadensin and its metabolites.
• Isolation and structural elucidation of nevadensin glucuronides using Nuclear Magnetic Resonance (NMR) spectroscopy.
• Proteomic screening of UGT isoforms in relevant cell lines.
• Assessment of nevadensin's inhibitory effects on sulfotransferase (SULT) activity.

Main Results:

• Significant cell line-dependent differences in nevadensin's toxic effects were observed, with HepG2 and KG1 cells being more sensitive than HT29 cells.
• Nevadensin was rapidly glucuronidated in HT29 cells, while KG1 cells showed minimal metabolism, suggesting glucuronidation as a key pathway.
• Nevadensin-7-O-glucuronide was identified as a metabolite, and UGT1A6 and UGT1A1 were implicated in nevadensin glucuronidation.
• Nevadensin demonstrated potent inhibition of SULT activity in HepG2 cells.

Conclusions:

• Cellular metabolic competence plays a critical role in determining the in vitro toxicity of nevadensin.
• Glucuronidation is a significant metabolic pathway for nevadensin, influencing its toxicological outcomes.
• The findings underscore the necessity of considering cell line-specific metabolic characteristics when evaluating the toxic endpoints of xenobiotics.